The estimated Net Worth of Healthcare Capital Partners... is at least $30.9 million dollars as of 18 March 2019. Healthcare Partners owns over 500,000 units of KalVista Pharmaceuticals Inc stock worth over $16,552,881 and over the last 6 years Healthcare sold KALV stock worth over $14,375,000.
Healthcare has made over 1 trades of the KalVista Pharmaceuticals Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Healthcare sold 500,000 units of KALV stock worth $14,375,000 on 18 March 2019.
The largest trade Healthcare's ever made was selling 500,000 units of KalVista Pharmaceuticals Inc stock on 18 March 2019 worth over $14,375,000. On average, Healthcare trades about 500,000 units every 0 days since 2019. As of 18 March 2019 Healthcare still owns at least 1,544,112 units of KalVista Pharmaceuticals Inc stock.
You can see the complete history of Healthcare Partners stock trades at the bottom of the page.
Over the last 8 years, insiders at KalVista Pharmaceuticals Inc have traded over $74,823,944 worth of KalVista Pharmaceuticals Inc stock and bought 4,877,063 units worth $58,591,487 . The most active insiders traders include Holdings A/S Novo, Capital Management, L.P.Ra ... et Rajeev M. Shah. On average, KalVista Pharmaceuticals Inc executives and independent directors trade stock every 19 days with the average trade being worth of $835,088. The most recent stock trade was executed by Benjamin L Palleiko on 6 September 2024, trading 15,625 units of KALV stock currently worth $167,500.
kalvista is a clinical stage pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors.
KalVista Pharmaceuticals Inc executives and other stock owners filed with the SEC include: